These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhalable lactoferrin-chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma. Abd Elwakil MM; Mabrouk MT; Helmy MW; Abdelfattah EA; Khiste SK; Elkhodairy KA; Elzoghby AO Nanomedicine (Lond); 2018 Aug; 13(16):2015-2035. PubMed ID: 30191764 [TBL] [Abstract][Full Text] [Related]
5. Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells. Saleh T; Soudi T; Shojaosadati SA Int J Biol Macromol; 2019 Jun; 130():109-116. PubMed ID: 30802519 [TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor. Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma. Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813 [TBL] [Abstract][Full Text] [Related]
8. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation. Qu N; Sun Y; Li Y; Hao F; Qiu P; Teng L; Xie J; Gao Y Biomed Eng Online; 2019 Jan; 18(1):11. PubMed ID: 30704488 [TBL] [Abstract][Full Text] [Related]
10. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue. Abbas Y; Azzazy HM; Tammam S; Lamprecht A; Ali ME; Schmidt A; Sollazzo S; Mathur S Colloids Surf B Biointerfaces; 2016 Oct; 146():19-30. PubMed ID: 27244047 [TBL] [Abstract][Full Text] [Related]
11. Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles. Nafee N; Gaber DM; Elzoghby AO; Helmy MW; Abdallah OY Pharm Res; 2020 Apr; 37(4):82. PubMed ID: 32291520 [TBL] [Abstract][Full Text] [Related]
12. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer. Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703 [TBL] [Abstract][Full Text] [Related]
14. HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment. Shen Y; Li W Drug Des Devel Ther; 2018; 12():2285-2292. PubMed ID: 30087553 [TBL] [Abstract][Full Text] [Related]
15. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery. Wang Z; Li Z; Zhang D; Miao L; Huang G Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038 [TBL] [Abstract][Full Text] [Related]
16. Inhalable Dual-Targeted Hybrid Lipid Nanocore-Protein Shell Composites for Combined Delivery of Genistein and All-Trans Retinoic Acid to Lung Cancer Cells. Kamel NM; Helmy MW; Abdelfattah EZ; Khattab SN; Ragab D; Samaha MW; Fang JY; Elzoghby AO ACS Biomater Sci Eng; 2020 Jan; 6(1):71-87. PubMed ID: 33463208 [TBL] [Abstract][Full Text] [Related]
17. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates. Abdelaziz HM; Gaber M; Abd-Elwakil MM; Mabrouk MT; Elgohary MM; Kamel NM; Kabary DM; Freag MS; Samaha MW; Mortada SM; Elkhodairy KA; Fang JY; Elzoghby AO J Control Release; 2018 Jan; 269():374-392. PubMed ID: 29180168 [TBL] [Abstract][Full Text] [Related]
18. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Tomoda K; Ohkoshi T; Hirota K; Sonavane GS; Nakajima T; Terada H; Komuro M; Kitazato K; Makino K Colloids Surf B Biointerfaces; 2009 Jul; 71(2):177-82. PubMed ID: 19264458 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect Li F; Wang Y; Chen WL; Wang DD; Zhou YJ; You BG; Liu Y; Qu CX; Yang SD; Chen MT; Zhang XN Theranostics; 2019; 9(20):5886-5898. PubMed ID: 31534526 [TBL] [Abstract][Full Text] [Related]